GIMV NV (GIMB) - Total Liabilities

Latest as of September 2025: €422.95 Million EUR ≈ $494.47 Million USD

Based on the latest financial reports, GIMV NV (GIMB) has total liabilities worth €422.95 Million EUR (≈ $494.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore GIMV NV (GIMB) cash flow conversion to assess how effectively this company generates cash.

GIMV NV - Total Liabilities Trend (2007–2025)

This chart illustrates how GIMV NV's total liabilities have evolved over time, based on quarterly financial data. Check GIMB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

GIMV NV Competitors by Total Liabilities

The table below lists competitors of GIMV NV ranked by their total liabilities.

Company Country Total Liabilities
Nurix Therapeutics Inc
NASDAQ:NRIX
USA $150.22 Million
FMC Corporation
NYSE:FMC
USA $7.59 Billion
JiangXi Tianxin Pharm Co Ltd
SHG:603235
China CN¥1.07 Billion
Alembic Pharmaceuticals Limited
NSE:APLLTD
India Rs30.81 Billion
Anhui Guangxin Agrochemical Co Ltd
SHG:603599
China CN¥5.12 Billion
Kunshan Huguang Auto Harness Co Ltd
SHG:605333
China CN¥5.42 Billion
CLARIVATE PLC
NYSE:CLVT
USA $6.23 Billion
RAPT Therapeutics Inc
NASDAQ:RAPT
USA $13.76 Million

Liability Composition Analysis (2007–2025)

This chart breaks down GIMV NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of GIMV NV.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 32.25 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.21 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GIMV NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GIMV NV (2007–2025)

The table below shows the annual total liabilities of GIMV NV from 2007 to 2025.

Year Total Liabilities Change
2025-03-31 €458.27 Million
≈ $535.76 Million
+7.09%
2024-03-31 €427.94 Million
≈ $500.30 Million
+6.08%
2023-03-31 €403.41 Million
≈ $471.63 Million
-2.99%
2022-03-31 €415.83 Million
≈ $486.15 Million
-9.46%
2021-03-31 €459.28 Million
≈ $536.94 Million
+66.64%
2020-03-31 €275.61 Million
≈ $322.21 Million
+1049.23%
2019-03-31 €23.98 Million
≈ $28.04 Million
+44.04%
2018-03-31 €16.65 Million
≈ $19.47 Million
-54.18%
2017-03-31 €36.34 Million
≈ $42.48 Million
+3.07%
2016-03-31 €35.26 Million
≈ $41.22 Million
+98.70%
2015-03-31 €17.74 Million
≈ $20.74 Million
-25.10%
2014-03-31 €23.69 Million
≈ $27.69 Million
-54.27%
2013-03-31 €51.80 Million
≈ $60.56 Million
-83.06%
2012-03-31 €305.75 Million
≈ $357.46 Million
-46.50%
2011-03-31 €571.47 Million
≈ $668.11 Million
-0.81%
2010-03-31 €576.14 Million
≈ $673.57 Million
-3.64%
2009-03-31 €597.88 Million
≈ $698.98 Million
+26.97%
2008-03-31 €470.88 Million
≈ $550.50 Million
+59.75%
2007-03-31 €294.76 Million
≈ $344.60 Million
--

About GIMV NV

BR:GIMB Belgium Asset Management
Market Cap
$2.07 Billion
€1.77 Billion EUR
Market Cap Rank
#7004 Global
#35 in Belgium
Share Price
€48.20
Change (1 day)
-1.43%
52-Week Range
€40.75 - €49.30
All Time High
€49.30
About

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, pre-revenue, middle market, debt, shareholder loans, seed, startups, early to mid-stage, mezzanine, late venture, emerging growth, public to private transactions, small and medium sized enterprises, later stage, mature,… Read more